Page last updated: 2024-08-23

bezafibrate and niacin

bezafibrate has been researched along with niacin in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19902 (8.70)18.7374
1990's8 (34.78)18.2507
2000's7 (30.43)29.6817
2010's6 (26.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Cramb, R; Florkowski, CM1
Krishnamurthy, A; Thapar, GS1
Hambrecht, R; Kübler, W; Schuler, G; Tischbirek, K; von Hodenberg, E1
Kostner, GM1
Franceschini, G; Paoletti, R; Sirtori, CR1
Luria, MH; Sapoznikov, D1
Jokubaitis, LA2
Sinzinger, H1
Friedman, M; Haimov, T; Hoffman, A; Lomnicky, Y; Luria, MH1
Isles, CG; Paterson, JR1
Kawamori, R; Onuma, T1
Matsuzawa, Y; Nagai, Y; Takemura, K; Yamashita, S; Yanagi, K1
Mal', GS1
Ascaso, JF; Felipe Pallardo, L; Fernández-Cruz, A; González Santos, P; Hernández Mijares, A; Mangas Rojas, A; Millán, J; Pedro-Botet, J; Pérez-Jiménez, F; Pía, G; Pintó, X; Plaza, I; Rubiés-Prat, J1
Patel, J1
Nagao, M; Oikawa, S1
Critchley, WR; Shah, MK; Shaw, SM; Williams, SG; Yonan, N1

Reviews

11 review(s) available for bezafibrate and niacin

ArticleYear
Approaches to the management of hypercholesterolaemia.
    Journal of clinical pharmacy and therapeutics, 1992, Volume: 17, Issue:2

    Topics: Bezafibrate; Bile Acids and Salts; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Probucol

1992
The affection of lipoprotein-a by lipid lowering drugs.
    Progress in clinical and biological research, 1988, Volume: 255

    Topics: Arteriosclerosis; Bezafibrate; Cholestyramine Resin; Hormones; Humans; Hypolipidemic Agents; Lipoprotein(a); Lipoproteins; Neomycin; Niacin; Nicotinic Acids; Stanozolol

1988
Fluvastatin in combination with other lipid-lowering agents.
    British journal of clinical practice. Supplement, 1996, Volume: 77A

    Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Niacin; Randomized Controlled Trials as Topic

1996
[Antilipemic agents and atherothrombosis. Effects of antilipemic agents on blood platelet function, coagulation and fibrinolysis].
    Deutsche medizinische Wochenschrift (1946), 1998, Sep-18, Volume: 123, Issue:38

    Topics: Anticholesteremic Agents; Antiporters; Arteriosclerosis; Bezafibrate; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Clinical Trials as Topic; Clofibric Acid; Fenofibrate; Fibrinolysis; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lovastatin; Niacin; Pravastatin; Risk Factors; Simvastatin; Thrombosis

1998
Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    QJM : monthly journal of the Association of Physicians, 2000, Volume: 93, Issue:9

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Dietary Supplements; Female; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Life Style; Male; Middle Aged; Niacin; Patient Selection; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Simvastatin; Triglycerides

2000
[Drug combination therapies for patients with hyperlipidemia and its significance].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 3

    Topics: Anion Exchange Resins; Bezafibrate; Cholesterol, LDL; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Niacin

2001
[Treatment of high blood cholesterol in patients with coronary heart disease].
    Nihon rinsho. Japanese journal of clinical medicine, 1994, Volume: 52 Suppl, Issue:Pt 1

    Topics: Anion Exchange Resins; Bezafibrate; Clinical Trials as Topic; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Niacin; Probucol; Risk Factors

1994
Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: recommendations of the HDL Forum.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2004, Volume: 4, Issue:5

    Topics: Bezafibrate; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Niacin; Risk Assessment

2004
Dyslipidaemia in diabetes.
    Clinical evidence, 2006, Issue:15

    Topics: Azetidines; Bezafibrate; Diabetes Complications; Diabetic Angiopathies; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin

2006
[Intervention for hypertriglyceridemia].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Jul-28, Volume: 65 Suppl 7

    Topics: Aged; Bezafibrate; Clofibric Acid; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Humans; Hypertriglyceridemia; Male; Middle Aged; Niacin

2007
Second line options for hyperlipidemia management after cardiac transplantation.
    Cardiovascular therapeutics, 2013, Volume: 31, Issue:3

    Topics: Azetidines; Bezafibrate; Diet; Exercise; Ezetimibe; Fish Oils; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Niacin

2013

Trials

4 trial(s) available for bezafibrate and niacin

ArticleYear
Influence of bezafibrate, fenofibrate, nicotinic acid and etofibrate on plasma high-density lipoprotein levels.
    The American journal of cardiology, 1983, Aug-22, Volume: 52, Issue:4

    Topics: Adipose Tissue; Animals; Apolipoprotein C-II; Apolipoprotein C-III; Apolipoproteins; Apolipoproteins C; Bezafibrate; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Clofibric Acid; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipolysis; Lipoproteins, HDL; Niacin; Rats; Structure-Activity Relationship

1983
Fluvastatin in combination with other lipid-lowering agents.
    British journal of clinical practice. Supplement, 1996, Volume: 77A

    Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Niacin; Randomized Controlled Trials as Topic

1996
[Comparative efficiency of prolonged diet and drug therapies for hyperlipidemias in patients with ischemic heart disease].
    Klinicheskaia meditsina, 2004, Volume: 82, Issue:5

    Topics: Aged; Bezafibrate; Cholesterol, LDL; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Myocardial Ischemia; Niacin; Time Factors

2004
Fluvastatin in combination with other lipid-lowering agents.
    British journal of clinical practice. Supplement, 1994, Issue:77

    Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Humans; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Niacin; Randomized Controlled Trials as Topic

1994

Other Studies

9 other study(ies) available for bezafibrate and niacin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Effect of bezafibrate & nicotinic acid on triton induced hyperlipidemias in CFY rats.
    The Indian journal of medical research, 1991, Volume: 94

    Topics: Animals; Bezafibrate; Cholesterol; Drug Therapy, Combination; Hyperlipidemias; Male; Niacin; Polyethylene Glycols; Rats; Triglycerides

1991
[Type III hyperlipoproteinemia in monoclonal IgM gammopathy].
    Deutsche medizinische Wochenschrift (1946), 1991, Nov-08, Volume: 116, Issue:45

    Topics: Adult; Bezafibrate; Cholesterol; Dietary Fats; Female; Humans; Hypergammaglobulinemia; Hyperlipoproteinemia Type III; Immunoglobulin lambda-Chains; Immunoglobulin M; Lipids; Lovastatin; Niacin; Triglycerides

1991
Raising HDL cholesterol with low-dose nicotinic acid and bezafibrate: preliminary experience.
    Postgraduate medical journal, 1993, Volume: 69, Issue:810

    Topics: Aged; Bezafibrate; Cholesterol, HDL; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Triglycerides

1993
Pharmacodynamic effects of bezafibrate and niacin combination: implications of the mode of administration.
    Journal of pharmaceutical sciences, 2000, Volume: 89, Issue:8

    Topics: Animals; Bezafibrate; Cholesterol; Drug Therapy, Combination; Hyperlipidemias; Hypolipidemic Agents; Male; Niacin; Rats; Rats, Inbred Lew; Triglycerides

2000
Beyond statins: assessing the alternatives. Some people can't tolerate statins, and others need additional medications to achieve healthy cholesterol levels.
    Harvard heart letter : from Harvard Medical School, 2014, Volume: 25, Issue:3

    Topics: Anticholesteremic Agents; Azetidines; Bezafibrate; Cholesterol; Dietary Supplements; Exercise; Ezetimibe; Health Behavior; Health Promotion; Humans; Hyperlipidemias; Niacin

2014